The Sidney & Lois Eskenazi Hospital is a public hospital located in Indianapolis, Indiana. The hospital is the flagship medical center for Eskenazi Health, founded in 1859 as Indiana's oldest public healthcare system. The hospital is operated by Health & Hospital Corporation of Marion County.

There are 315 beds in Sidney and Lois Eskenazi Hospital.

During the past decade, Sidney and Lois Eskenazi Hospital conducted 56 clinical trials. In the 10-year time frame, 56 clinical trials started and 38 clinical trials were completed, i.e. on average, 67.9% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 25 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sidney and Lois Eskenazi Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 38 trials, followed by "SWOG Cancer Research Network" with 11 trials sponsored, "Alliance for Clinical Trials in Oncology" with 9 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 7 trials sponsored and "Pfizer" with 7 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sidney and Lois Eskenazi Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 32 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator and "NCIC Clinical Trials Group" with 4 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Sidney and Lois Eskenazi Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Invasive Breast Carcinoma" (6 trials), "Recurrent Breast Carcinoma" (6 trials) and "Breast Cancer" (5 trials). Many other conditions were trialed in "Sidney and Lois Eskenazi Hospital" in a lesser frequency.

Most popular intervention types in "Sidney and Lois Eskenazi Hospital" are "Drug" (62 trials), "Other" (55 trials), "Biological" (33 trials), "Procedure" (23 trials) and "Radiation" (13 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (36 trials), "Quality-of-Life Assessment" (17 trials), "Nivolumab" (13 trials), "Questionnaire Administration" (11 trials) and "Cisplatin" (10 trials). Other intervention names were less common.

The vast majority of trials in "Sidney and Lois Eskenazi Hospital" are 63 trials for "All" genders, 19 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Sidney and Lois Eskenazi Hospital". 1 are not yet recruiting, 12 are recruiting, 43 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Sidney and Lois Eskenazi Hospital, 2 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Sidney and Lois Eskenazi Hospital, 2 "Phase 1" clinical trials were conducted, 37 "Phase 2" clinical trials and 45 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".